cotta <3359> Acquires MedMarge, an Online Cosmetic Medicine Service Provider – d menu news

Background of cotta's Subsidiary Acquisition of MedMarge

The news of cotta making MedMarge, an online cosmetic medicine service provider, a subsidiary might initially be perceived as an entry into the medical field from a different industry. However, it signifies the advancement of DX in the healthcare sector and the new possibilities for business succession and M&A that accompany it. cotta is a major e-commerce player in confectionery and bakery ingredients, and it aims to leverage its expertise in operating e-commerce platforms and its customer base in the growing field of cosmetic medicine. This is not merely a capital alliance but a move to provide and expand medical services utilizing digital technology, suggesting to healthcare executives the necessity of simultaneously considering their own institution's digital strategy and business succession.

Implications in the Context of Medical M&A and Business Succession

This case indicates that when medical institutions consider their own succession, they should consider not only transfers to traditional peers but also options such as collaboration with different industries and business restructuring based on DX. Particularly, medical institutions that actively incorporate digital technologies like online consultations and remote medicine can become attractive M&A targets for companies with expertise in DX. The utilization of online platforms like MedMarge can potentially lead to acquiring new customer segments and expanding service offerings, even for community-based clinics, and will be a crucial factor in envisioning growth strategies post-business succession.

Awareness for Healthcare Executives & Successors

When directors and heads of clinics consider future business succession, it is beneficial to explore how to digitize their institution's strengths and resources and create synergy with external companies. For medical institutions struggling with a lack of successors, advancing DX can enable M&A based on 'business expansion and diversification' rather than simple 'succession,' potentially leading to more favorable transfer terms and the establishment of a robust foundation for future business continuity. Concurrently considering one's own DX strategy and business succession plan from an early stage is key to avoiding closure and maintaining a sustainable healthcare delivery system.